Else Kröner Forschungskolleg Cologne: Overview

Principal Investigators

Improving the understanding of immunotherapy in patients with classical Hodgkin lymphoma

Univ.-Prof. Dr. med. Dr. h.c. Andreas Engert

Improving the understanding of immunotherapy in patients with classical Hodgkin lymphoma, Else Kröner Forschungskolleg Cologne

Employing deep genomic sequencing to reveal the biological principles of neuroblastoma

Univ.-Prof. Dr. med. Matthias Fischer

Employing deep genomic sequencing to reveal the biological principles of neuroblastoma, Else Kröner Forschungskolleg Cologne

Translational CLL research to develop new standards of clinical care

Univ.-Prof. Dr. med. Michael Hallek

Translational CLL research to develop new standards of clinical care, Else Kröner Forschungskolleg Cologne

Cancer genomics to understand tumor characteristics and vulnerabilities

PD Dr. Axel Hillmer

Cancer genomics to understand tumor characteristics and vulnerabilities, Else Kröner Forschungskolleg Cologne

Understanding the principles of protein homeostasis in cancer and aging

Univ.-Prof. Dr. rer. nat. Thorsten Hoppe

Understanding the principles of protein homeostasis in cancer and aging, Else Kröner Forschungskolleg Cologne

Deciphering the principles of skin cancer

Dr. rer. nat. Sandra Iden

Deciphering the principles of skin cancer, Else Kröner Forschungskolleg Cologne

Cell Death and Immunity

Prof. Dr. rer. nat. Hamid Kashkar

Cell Death and Immunity, Else Kröner Forschungskolleg Cologne

Developing high performance computing infrastructure to facilitate the genomic profiling of tumor specimens

Univ.-Prof. Dr.-Ing. Ulrich Lang

Developing high performance computing infrastructure to facilitate the genomic profiling of tumor specimens, Else Kröner Forschungskolleg Cologne

Cell polarity and the pathogenesis of skin cancer

Univ.-Prof. Dr. rer. nat. Carien Niessen

Cell polarity and the pathogenesis of skin cancer, Else Kröner Forschungskolleg Cologne

Using state of the art mouse models to uncover principles of cell death and cancerogenesis

Univ.-Prof. Dr. rer. nat. Manolis Pasparakis

Using state of the art mouse models to uncover principles of cell death and cancerogenesis, Else Kröner Forschungskolleg Cologne

Developing novel computational algorithms to decipher genomic principles of malignant transformation and clonal evolution

Univ.-Prof. Dr. Martin Peifer

Developing novel computational algorithms to decipher genomic principles of malignant transformation and clonal evolution, Else Kröner Forschungskolleg Cologne

Oncological Imaging Group

Priv.-Doz. Dr. Thorsten Persigehl

Oncological Imaging Group, Else Kröner Forschungskolleg Cologne

Employing genetically engineered mouse models as preclinical platforms

Univ.-Prof. Dr. med. H. Christian Reinhardt

Employing genetically engineered mouse models as preclinical platforms, Else Kröner Forschungskolleg Cologne

Focusing on the molecular mechanisms of the DNA damage response

Univ.-Prof. Dr. Björn Schumacher

Focusing on the molecular mechanisms of the DNA damage response, Else Kröner Forschungskolleg Cologne

Epigenetic aberrations as key drivers of malignant transformation and clonal evolution

Univ.-Prof. Dr. Dr. Michal-Ruth Schweiger

Epigenetic aberrations as key drivers of malignant transformation and clonal evolution, Else Kröner Forschungskolleg Cologne

Pharmacogenomics to reveal cancer-specific molecular vulnerabilities

Univ.-Prof. Dr. med. Martin Sos

Pharmacogenomics to reveal cancer-specific molecular vulnerabilities, Else Kröner Forschungskolleg Cologne

Translational genomics to understand the impact of cancer-specific somatic mutations in lung cancer evolution

Univ.-Prof. Dr. med. Roman Thomas

Translational genomics to understand the impact of cancer-specific somatic mutations in lung cancer evolution, Else Kröner Forschungskolleg Cologne

Immunotherapeutic approaches and their combination with anti-angiogenetic treatment

PD Dr. med. Dr. nat. med. Roland Ullrich

Immunotherapeutic approaches and their combination with anti-angiogenetic treatment, Else Kröner Forschungskolleg Cologne

The Lung Cancer Group Cologne serves as a translational hub within the EKFS consortium

Univ.-Prof. Dr. med. Jürgen Wolf

The Lung Cancer Group Cologne serves as a translational hub within the EKFS consortium, Else Kröner Forschungskolleg Cologne

Using mouse models to understand the impact of rewired metabolism and inflammatory processes on cancer development and progression

PD Dr. rer. nat. F. Thomas Wunderlich

Using mouse models to understand the impact of rewired metabolism and inflammatory processes on cancer development and progression, Else Kröner Forschungskolleg Cologne

The Gastrointestinal Cancer Group Cologne: Translational research to develop genotype tailored therapies

PD Dr. med. Thomas Zander

The Gastrointestinal Cancer Group Cologne: Translational research to develop genotype tailored therapies, Else Kröner Forschungskolleg Cologne

top